November 25, 2008

HELIX BIOPHARMA FILES FORM 20-F REGISTRATION STATEMENT WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION (PDF)

(AURORA, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP”) has filed a Form 20-F Registration Statement with the United States Securities and Exchange Commission, to register its common shares with the SEC.